Brophy Michael Burkes

CFO Brophy Michael Burkes sells 5,063 shares for $1,001,645.17; strong cross-ticker track record (47.06% well-timed rate), but recent same-ticker sales underperformed.

Brophy Michael Burkes, CFO of Natera (NTRA), executed 7 separate sales totaling 5,063 shares for $1,001,645.17 between April 27–29, 2026, reducing holdings by 8.0% to 58,291 shares. The blended average transaction price of $197.84 sits close to the current price of $194.75, while the stock has declined 23.4% from its 52-week high of $254.40. Across his cross-ticker trading history, Burkes has posted a 47.06% well-timed rate on prior sells (20 sells with 4.8% average 30-day return), suggesting disciplined execution patterns. However, at NTRA specifically, his five prior sales show consistent underperformance: three February 2026 sells each declining 12.5–14.6% within 30 days, and two January 2026 sells yielding negative 90-day returns of -15.3% and -15.7%—both well-timed. The company remains unprofitable (-$87.5M net income on $592.2M quarterly revenue) despite strong 35.9% annual revenue growth. This sale occurs against a backdrop of prior same-ticker underperformance and ongoing losses, warranting monitoring of whether future price action aligns with historical patterns or signals shifting company dynamics.

CFO Brophy Michael Burkes sells 6,939 shares at $227.83 avg; stock down 19.2% from 52-week high, recent 30-day drop 13.4%

Brophy Michael Burkes, Chief Financial Officer of Natera, Inc., executed 3 separate sales totaling 6,939 shares for $1,580,926.39 on 2026-02-03 at prices ranging from $225.25 to $230.77 (blended average $227.83). This represents an 11.7% reduction in his holdings from 59,059 to 52,120 shares. The transaction occurred amid notable recent weakness in NTRA: the stock is currently trading at $205.61, down 19.2% from its 52-week high of $254.40 and down 13.4% over the prior 30 days, though up 3.6% over 90 days. Natera's latest quarter showed $592.2M in revenue with 56.8% annual growth, but the company remains unprofitable with $-87.5M in net income and a $28.4B market cap. Critically, Burkes has executed 5 separate sells at this ticker within the past week (2026-01-27 through 2026-02-03), yet his cross-ticker track record shows a 0.00% well-timed rate on 20 prior sells historically, indicating his timing decisions have not typically preceded stock declines.

CFO Michael Burkes sells 5,064 shares at avg $235.38 in 5 transactions over Jan 27–29; holds 59,059 post-sale.

Michael Burkes, NTRA's CFO, executed five separate sales totaling 5,064 shares for $1,191,953.30 between January 27 and 29, 2026, at prices ranging from $229.94 to $240.53—a blended average of $235.38. This represents a 7.9% reduction from his pre-transaction holdings of 64,123 shares, leaving him with 59,059 shares. The sales occurred near the stock's 52-week high of $254.40 (current price $231.48 is 9.0% below that peak), and follow a pattern of recent seller activity at NTRA: Burkes executed three prior sales on January 20–21, 2026, just days earlier. His longer-dated same-ticker sells (October 2025) subsequently appreciated 25.1–27.6% over 90 days, indicating poor timing on those trades. Against this backdrop, the current sale cluster occurs as the company reports negative net income of -$87,544,000 for its latest quarter despite strong 56.8% annual revenue growth, creating tension between growth metrics and profitability that investors and insiders may be processing differently. The proximity of all recent sales and the repeated selling pattern at this insider's prior opportunities merit monitoring.

CFO Michael Brophy sells 61,123 shares for $14.6M across three transactions (Jan 20-21), reducing stake by 48.8%

Michael Brophy, CFO of Natera, executed three separate sales totaling 61,123 shares for $14,638,100.25 on January 20-21, 2026, reducing his holdings from 125,246 shares to 64,123 shares—a 48.8% reduction in his position. The company trades at $242.91 (near its 52-week high of $254.40) and has achieved 56.8% annual revenue growth, though it remains unprofitable with a negative net income of $-87,544,000 over its most recent full fiscal year. Notably, Brophy's prior trades at NTRA (five sales in late October 2025) each showed strong 30-day positive returns ranging from 23.8% to 26.8%, indicating he has demonstrated timing acumen at this ticker. This large reduction in the CFO's stake warrants investor attention given the substantial dollar amount, the meaningful reduction in personal exposure, and the context of an unprofitable yet rapidly growing company trading near its high.

CFO Brophy Michael Burkes sold 5,063 shares of NTRA (9 transactions totaling $967.8K) at blended price $191.15 vs current $192.81

Brophy Michael Burkes, CFO of Natera, executed 9 separate sales totaling 5,063 shares for $967,777.75 over three trading days (2025-10-27 through 2025-10-29), reducing his holdings by 7.3% to 64,126 shares. The sales occurred near the stock's 52-week high of $195.00, with the blended average price of $191.15 only 1.1% below the current price of $192.81. At the same-ticker level, his prior 5 trades at NTRA show poor timing: only 1 of 5 prior sales were well-timed at the 90-day mark, with the last three July sells posting +21.6%, +22.2%, and +23.4% gains respectively over 30 days. The company remains unprofitable (net income of $-100.9M) while reporting strong annual revenue growth of +56.8%, creating a mixed fundamental backdrop. The multi-transaction structure and timing near recent highs warrant monitoring, though the small reduction in absolute holdings suggests this is not a material confidence signal.

CFO Brophy Michael Burkes sells 5,064 shares ($700.7K) across 4 transactions at NTRA; all 5 prior NTRA sells were well-timed (90d negative returns).

Brophy Michael Burkes, CFO of Natera, Inc., executed 4 separate sales totaling 5,064 shares for $700,670.43 on 2025-07-28 and 2025-07-29, reducing holdings by 7.2% to 65,430 shares. His prior trade history at this ticker is notably consistent: all 5 of his previous NTRA sells showed negative 90-day returns (ranging from -11.2% to -8.7%), indicating a pattern of well-timed exits before stock declines. The company remains unprofitable with net income of $-66,936,000.00 over the most recent full fiscal year, though revenue growth is strong at +56.8% annually. With the stock currently trading at $140.96, down 20.4% from its 52-week high of $177.00 and down 16.6% over the past 30 days, this sale occurs during a period of deteriorating near-term momentum, consistent with his demonstrated pattern of selling ahead of further price weakness.

CFO Brophy Michael Burkes sold 5,063 shares of NTRA (at blended avg $153.38) for $776,587.66 across 5 transactions in late April 2025.

Brophy Michael Burkes, Chief Financial Officer of Natera, executed five separate sales totaling 5,063 shares (5.1K shares) for $776,587.66 on April 28–29, 2025, reducing his holdings from 75,557 to 70,494 shares, a -6.7% reduction. The sales occurred at prices ranging from $152.18 to $155.44, blending to $153.38, which sits above the current price of $150.93. His prior sales at NTRA (five trades on 2025-02-03 and 2025-01-31) posted sharply negative 30-day returns (-10.1% to -17.0%), though longer-term outcomes remain unmeasurable for most. The company carries significant financial stress—reporting net income of $-31.6M in the latest quarter and an unprofitable full fiscal year—despite 56.8% annual revenue growth and a very elevated P/E of 686.05. The pattern of repeated sales over the past quarter, combined with persistent losses and an extremely elevated valuation multiple, merits investor attention to the company's path to profitability and cash burn trajectory.

CFO Brophy Michael Burkes sold 43,902 shares of NTRA for $7,763,862.18 across 5 transactions, reducing holdings by 38.3%.

Brophy Michael Burkes, CFO of Natera, executed 5 separate sales totaling 43,902 shares for $7,763,862.18 between January 31 and February 3, 2025, at prices ranging from $173.05 to $178.19, reducing his holdings from 114,531 shares to 70,629 shares. The company is unprofitable (net income of $-31,592,000.00 in the most recent quarter) despite strong revenue growth of +32.0% year-over-year and a substantial market cap of $23.0B. The CFO's cross-ticker sales history shows a poorly-timed 90-day outcome pattern (average 90-day return of +31.3% after his prior sells, with only 0.00% well-timed rate), indicating he has historically sold before rallies rather than declines. The current price of $174.24 is only 1.5% below the 52-week high of $176.92, suggesting limited downside protection near recent peaks.

CFO Brophy Michael Burkes sold 6,221 shares of NTRA for $1,052,112.05 in 5 transactions on Jan 29-31, 2025.

Brophy Michael Burkes, CFO of Natera, Inc., executed 5 separate sales totaling 6,221 shares for $1,052,112.05 between January 29 and January 31, 2025, reducing his holdings by 5.8% from 108,032 to 101,811 shares. The stock has appreciated 11.8% over the last 30 days and 42.5% over 90 days, currently trading at $176.92, which matches the 52-week high. His prior trades at NTRA (5 other transactions) show a 0% well-timed rate at the 90-day mark, with only 2 measurable historical outcomes: a -5.5% return 30 days after a July 2024 sale and +30.9% return after a February 2024 sale. The company, while unprofitable in its most recent full fiscal year (net income $-31,592,000.00), is growing revenue at 32.0% annually and generated $439,758,000.00 in latest quarter revenue. The timing of these sales against the backdrop of strong recent stock appreciation and sustained unprofitability warrants monitoring.

CFO Brophy Michael Burkes sold 25,931 shares of NTRA for $4,277,735.15 on 2025-01-22 at blended average price $164.97

Brophy Michael Burkes, Chief Financial Officer of Natera, Inc., executed 2 separate sales totaling 25,931 shares for $4,277,735.15, reducing his holdings by -19.1% from 135,596 to 109,665 shares. At his prior trades at NTRA (3 sales in 2024), the 90-day outcomes were mixed: one sale declined 5.5%, while two others gained 30.9% and 32.0% respectively, with 0 of 3 prior sales proving well-timed at the 90-day mark. The company reported quarterly revenue of $439,758,000.00 with a net loss of $-31,592,000.00 and remains unprofitable on a full-year basis, despite +32.0% annual revenue growth. The stock has advanced +6.1% over 30 days and +44.3% over 90 days, trading at $171.93, -2.6% from its 52-week high of $176.61.